Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01094054 · ClinicalTrials.gov registry record · Phase 4

Adjustable Gastric Banding and Its Effects on Postprandial Glucose Metabolism Independent of Weight Loss

A Phase 4 study, sponsored by Mayo Clinic.

Completed
Registry status
Phase 4
Development phase
29
Enrollment target

NCT01094054: Completed Phase 4 study, sponsored by Mayo Clinic.

NCT01094054 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 29 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01094054, a Phase 4 study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 4
Development phase
29 participants
Enrollment target

Study Summary

The overall aim is to determine the mechanism(s) by which common bariatric surgical procedures alter carbohydrate metabolism. Understanding these mechanisms may ultimately lead to the development of novel interventions for the prevention and treatment of Type 2 diabetes and obesity.

Primary Outcome

Insulin sensitivity which measures the overall ability of insulin to stimulate glucose disposal and inhibit glucose production will be calculated from plasma glucose and insulin concentrations using the "oral" glucose minimal model. Beta-cell responsivity indices will be calculated using plasma glucose and C-peptide concentrations using the oral C-peptide minimal model. The appropriateness of insulin secretion for the prevailing degree of insulin action is assessed by calculating the total dispo

Interventions

  • PROCEDURE Adjustable gastric banding
  • BEHAVIORAL Dietary and lifestyle modification

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2010-10
Est. Completion 2013-01
Phase Phase 4
Mayo Clinic

2,844 total trials

What the finished NCT01094054 record still lists

NCT01094054 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Adjustable gastric banding is the first listed.

NCT01094054 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01094054 about?

NCT01094054 is a clinical study titled "Adjustable Gastric Banding and Its Effects on Postprandial Glucose Metabolism Independent of Weight Loss". The overall aim is to determine the mechanism(s) by which common bariatric surgical procedures alter carbohydrate metabolism. Understanding these mechanisms may ultimately lead to the development of novel interventions for the prevention and treatment of Type 2 diabetes and obesity.

What is the current status of trial NCT01094054?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 29 participants. The study started on 2010-10. Estimated completion is 2013-01.

What interventions are being tested in trial NCT01094054?

The interventions under investigation include: Adjustable gastric banding (PROCEDURE), Dietary and lifestyle modification (BEHAVIORAL).

Who is sponsoring clinical trial NCT01094054?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01094054's enrollment target sits among peer trials

29 1634th of 2000 higher than 366 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01094054, the US trial registry maintained by the National Library of Medicine. NCT01094054 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.